S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10

Stryker Stock Forecast, Price & News

-0.71 (-0.26 %)
(As of 10/22/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume653,252 shs
Average Volume1.15 million shs
Market Capitalization$103.98 billion
P/E Ratio50.50
Dividend Yield0.95%
30 days | 90 days | 365 days | Advanced Chart
Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

Stryker logo

About Stryker

Stryker Corp. engages in the provision of medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg, and Neurotechnology & Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The MedSurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling and reprocessed medical devices. The Neurotechnology & Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.


See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Equipment
Year Founded

Sales & Book Value

Annual Sales
$14.35 billion
Cash Flow
$9.75 per share
Book Value
$34.82 per share


Net Income
$1.60 billion




Market Cap
$103.98 billion
Next Earnings Date
10/28/2021 (Confirmed)

Social Links


Overall MarketRank

2.78 out of 5 stars

Medical Sector

37th out of 1,359 stocks

Surgical & Medical Instruments Industry

4th out of 124 stocks

Analyst Opinion: 2.3Community Rank: 4.5Dividend Strength: 3.3Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -

Stryker (NYSE:SYK) Frequently Asked Questions

Is Stryker a buy right now?

22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 1 sell rating, 7 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Stryker stock.
View analyst ratings for Stryker
or view top-rated stocks.

What stocks does MarketBeat like better than Stryker?

Wall Street analysts have given Stryker a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Stryker wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.
View our earnings forecast for Stryker

How can I listen to Stryker's earnings call?

Stryker will be holding an earnings conference call on Thursday, October 28th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 416-621-4642 with passcode "7351349".

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) issued its earnings results on Monday, July, 26th. The medical technology company reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $2.12 by $0.13. The medical technology company had revenue of $4.29 billion for the quarter, compared to analyst estimates of $4.14 billion. Stryker had a trailing twelve-month return on equity of 26.08% and a net margin of 12.82%. The business's quarterly revenue was up 55.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.64 earnings per share.
View Stryker's earnings history

How has Stryker's stock price been impacted by Coronavirus?

Stryker's stock was trading at $175.62 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SYK shares have increased by 57.0% and is now trading at $275.73.
View which stocks have been most impacted by COVID-19

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker declared a quarterly dividend on Wednesday, August 4th. Stockholders of record on Thursday, September 30th will be paid a dividend of $0.63 per share on Friday, October 29th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend is Wednesday, September 29th.
View Stryker's dividend history

Is Stryker a good dividend stock?

Stryker pays an annual dividend of $2.52 per share and currently has a dividend yield of 0.95%. Stryker has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Stryker is 33.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Stryker will have a dividend payout ratio of 23.98% next year. This indicates that Stryker will be able to sustain or increase its dividend.
View Stryker's dividend history.

What guidance has Stryker issued on next quarter's earnings?

Stryker updated its FY 2021 earnings guidance on Tuesday, August, 3rd. The company provided earnings per share guidance of $9.250-$9.400 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.190. The company issued revenue guidance of -.

What price target have analysts set for SYK?

22 brokerages have issued 1-year target prices for Stryker's shares. Their forecasts range from $240.00 to $320.00. On average, they anticipate Stryker's stock price to reach $286.43 in the next year. This suggests a possible upside of 3.9% from the stock's current price.
View analysts' price targets for Stryker
or view top-rated stocks among Wall Street analysts.

Who are Stryker's key executives?

Stryker's management team includes the following people:
  • Kevin A. Lobo, Chairman, President & Chief Executive Officer (LinkedIn Profile)
  • Glenn S. Boehnlein, Chief Financial Officer & Vice President
  • Alan Douville, Chief Information Officer & Vice President
  • Dana S. McMahon, Chief Compliance Officer & Vice President
  • William E. Berry, Chief Accounting Officer & Vice President

What is Kevin A. Lobo's approval rating as Stryker's CEO?

1,492 employees have rated Stryker CEO Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among Stryker's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), The Walt Disney (DIS), The Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include DekaBank Deutsche Girozentrale (0.15%), Welch & Forbes LLC (0.14%), Pensioenfonds Rail & OV (0.11%), LGT Capital Partners LTD. (0.09%), Confluence Investment Management LLC (0.09%) and Villere ST Denis J & Co. LLC (0.08%). Company insiders that own Stryker stock include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Roch Doliveux, Ronda E Stryker, Srikant M Datar and Timothy J Scannell.
View institutional ownership trends for Stryker

Which institutional investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including Pensioenfonds Rail & OV, LGT Capital Partners LTD., Confluence Investment Management LLC, Villere ST Denis J & Co. LLC, Bedrijfstakpensioenfonds Voor DE Media PNO, PGGM Investments, Fifth Third Bancorp, and Strs Ohio. Company insiders that have sold Stryker company stock in the last year include Glenn S Boehnlein, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Ronda E Stryker, and Timothy J Scannell.
View insider buying and selling activity for Stryker
or view top insider-selling stocks.

Which institutional investors are buying Stryker stock?

SYK stock was purchased by a variety of institutional investors in the last quarter, including DekaBank Deutsche Girozentrale, Private Advisor Group LLC, Ayrshire Capital Management LLC, Tompkins Financial Corp, Stokes Capital Advisors LLC, BKD Wealth Advisors LLC, Pensionfund DSM Netherlands, and Crossmark Global Holdings Inc..
View insider buying and selling activity for Stryker
or or view top insider-buying stocks.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $275.73.

How much money does Stryker make?

Stryker has a market capitalization of $103.98 billion and generates $14.35 billion in revenue each year. The medical technology company earns $1.60 billion in net income (profit) each year or $7.43 on an earnings per share basis.

How many employees does Stryker have?

Stryker employs 2,020 workers across the globe.

Does Stryker have any subsidiaries?

The following companies are subsidiares of Stryker: ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc, Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, CHG Hospital Beds, Cactus LLC, Cardan Robotics, Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, Concentric Medical Inc., Entellus Medical, Entellus Medical Europe Ltd, Entellus Medical Inc., GYS Tech LLC, Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Technology Inc., ITAPCo Limited, Image Guided Technologies, Imorphics Limited, Infinity MSD Corp., Infinity MSE Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Germany GmbH, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Iberia Medcomtech S.L.U., K2M Inc., K2M Solutions Australia Pty Ltd, K2M Spine Solutions (Schweiz) GmbH, K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Hong Kong Ltd, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, OrthoSpace, OrthoSpace Ltd., OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, Patient Safety Technologies, Patton Surgical, Pficonprod Pty. Ltd., Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Czech Sales s.r.o., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Hungary Sales Kft, Physio-Control Inc., Physio-Control India Sales Pvt. Ltd, Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Physio-Control Singapore Pte. Ltd., Physio-Control South Africa Sales Pty. Ltd., Physio-Control UK Sales Ltd., Pivot Medical, PlasmaSol, Porex Technologies, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions BV, Stryker Asia Holdings CV, Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold BV, Stryker Beteiligungs GmbH, Stryker Canada GP ULC, Stryker Canada Holding Company, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Canadian Sales Holding Company ULC, Stryker Capital BV, Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services BV, Stryker Employment Company LLC, Stryker European Coordination Center BV, Stryker European Holdings Coöperatief U.A, Stryker European Holdings I LLC, Stryker European Holdings II LLC, Stryker European Holdings LLC, Stryker European Holdings V LLC, Stryker European Operations B.V., Stryker European Operations Holdings I BV, Stryker European Operations Holdings II BV, Stryker European Operations Holdings III BV, Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker European Technologies C.V., Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France Holding SNC, Stryker France MM Holdings SAS, Stryker France SAS, Stryker Funding B.V., Stryker GI Services CV, Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings BV, Stryker IFSC Designated Activity Company, Stryker Iberia SL Unipersonal, Stryker India Private Limited, Stryker International Acquisitions BV, Stryker International Holdings BV, Stryker Investment Holdings B.V., Stryker Ireland Holding Unlimited Company, Stryker Ireland Limited, Stryker Italia S.r.l. S.U., Stryker Japan Holdings BV, Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Holdings S.a.r.l., Stryker Luxembourg Sarl, Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland BV, Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Limited, Stryker Romania SRL, Stryker Sage Inc., Stryker Sales Corporation, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Trauma GmbH, Stryker Turkish Holdings BV, Stryker UK Ltd, Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TG SP Holdings Corp, TSO3 Corp, TSO3 Inc, Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (BVI) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, VEXIM SA, Vexim, Waterloo Bedding Co., Wright Medical Group, ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.

When was Stryker founded?

Stryker was founded in 1941.

What is Stryker's official website?

The official website for Stryker is www.strykercorp.com.

Where are Stryker's headquarters?

Stryker is headquartered at 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at (269) 385-2600 or via email at [email protected].

This page was last updated on 10/24/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.